HomeALGS • NASDAQ
add
Aligos Therapeutics Inc
Previous close
$10.88
Day range
$10.10 - $10.83
Year range
$3.76 - $46.80
Market cap
62.74M USD
Avg Volume
68.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 965.00K | -9.05% |
Operating expense | 5.56M | -12.86% |
Net income | -15.86M | -413.44% |
Net profit margin | -1.64K | -444.62% |
Earnings per share | -1.53 | -304.00% |
EBITDA | -18.31M | 30.01% |
Effective tax rate | -1.18% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 122.94M | 30.05% |
Total assets | 134.71M | 23.80% |
Total liabilities | 32.84M | -21.02% |
Total equity | 101.87M | — |
Shares outstanding | 6.15M | — |
Price to book | 0.66 | — |
Return on assets | -32.53% | — |
Return on capital | -39.83% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -15.86M | -413.44% |
Cash from operations | -15.50M | 20.46% |
Cash from investing | -39.42M | -198.57% |
Cash from financing | -177.00K | -162.99% |
Net change in cash | -55.10M | -365.16% |
Free cash flow | -8.68M | 6.72% |
About
Founded
2018
Headquarters
Website
Employees
70
